# FoxO3a regulated by miR-150-5p promotes the pyroptosis of macrophages in atherosclerosis

**Authors:** Ping-yu Cai, Mei-mei Li, Shu-han Chen, Yan-li Zheng, Jun Li, De-hong Huang, Jing-ru Du, Hui-li Lin

PMC · DOI: 10.1371/journal.pone.0327075 · PLOS One · 2025-10-17

## TL;DR

This study shows that miR-150-5p promotes macrophage pyroptosis in atherosclerosis by regulating FoxO3a, suggesting miR-150-5p inhibitors could be a new treatment approach.

## Contribution

The study identifies miR-150-5p as a regulator of FoxO3a and macrophage pyroptosis in atherosclerosis, offering a novel therapeutic target.

## Key findings

- miR-150-5p levels increase while FoxO3a levels decrease in atherosclerosis tissue exosomes.
- miR-150-5p inhibition reduces macrophage pyroptosis and improves cell viability in ox-LDL-induced injury.
- FoxO3a knockdown weakens the anti-pyroptotic effects of miR-150-5p inhibitors in mice.

## Abstract

This study uses tissue exosome analysis to explore the role of miR-150-5p and its downstream genes in atherosclerosis (AS), an area where the functional mechanisms and pathophysiological significance of exosomal miR-150-5p remain poorly understood.

Exosomes from AS mouse vascular tissue were analyzed to identify miR-150-5p target genes. Dual luciferase assays validated miRNA-target interactions, while RT-qPCR and Western blot assessed FoxO3a expression. RNA interference studies determined FoxO3a’s role in pyroptosis. In vivo efficacy of the miR-150-5p inhibitor was evaluated using HE, Masson staining, and immunofluorescence.

In AS tissue exosomes, miR-150-5p levels increased whereas FoxO3a levels decreased. miR-150-5p regulated FoxO3a, enhancing macrophage pyroptosis. The miR-150-5p inhibitor reduced ox-LDL-induced RAW264.7 injury and pyroptosis by improving cell viability, decreasing LDH levels, and downregulating pyroptosis related proteins (Caspase-1, NLRP3, GSDMD-N). FoxO3a knockdown weakened the inhibitor’s effects on NLRP3/GSDMD-mediated pyroptosis. In Apoe−/− mice, the inhibitor upregulated FoxO3a/ARC and suppressed pyroptosis signaling.

This study advances understanding of miR-150-5p-mediated pyroptosis and highlights the potential of miR-150-5p inhibitors in combating AS.

## Linked entities

- **Genes:** FOXO3 (forkhead box O3) [NCBI Gene 2309], Caspase1 (caspase-1) [NCBI Gene 692604], NLRP3 (NLR family pyrin domain containing 3) [NCBI Gene 114548], ARC (activity regulated cytoskeleton associated protein) [NCBI Gene 23237]
- **Proteins:** Caspase1 (caspase-1), NLRP3 (NLR family pyrin domain containing 3), ARC (activity regulated cytoskeleton associated protein)
- **Diseases:** atherosclerosis (MONDO:0005311)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** Foxo3 (forkhead box O3) [NCBI Gene 56484] {aka 1110048B16Rik, 2010203A17Rik, FKHRL1, Fkhr2, Foxo3a}, Gsdmd (gasdermin D) [NCBI Gene 69146] {aka 1810036L03Rik, DF5L, Dfna5l, GsdmD-1, Gsdmdc1, M2-4}, Nlrp3 (NLR family, pyrin domain containing 3) [NCBI Gene 216799] {aka AGTAVPRL, AII/AVP, Cias1, FCAS, FCU, MWS}, Casp1 (caspase 1) [NCBI Gene 12362] {aka ICE, Il1bc}
- **Diseases:** AS (MESH:D050197)
- **Species:** Mus musculus (house mouse, species) [taxon 10090]
- **Cell lines:** RAW264.7 — Mus musculus (Mouse), Mouse leukemia, Cancer cell line (CVCL_0493)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12533854/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12533854/full.md

## References

33 references — full list in the complete paper: https://tomesphere.com/paper/PMC12533854/full.md

---
Source: https://tomesphere.com/paper/PMC12533854